Loading stock data…
$72.61-1.14 (-1.55%)
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.
ANI Pharmaceuticals, Inc. in the Healthcare sector is trading at $72.61 with a market capitalization of $1.7B. Wall Street consensus targets $105.78 (9 analysts), implying a +45.7% move over the next 12 months. The stock is currently near its 52-week low of $69.58, remaining 6.8% below its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $266.04M↑ | $237.46M↓ | $247.06M↑ | $227.81M↑ | $211.37M |
| Gross Profit | $165.89M↑ | $143.88M↓ | $146.79M↑ | $134.42M↓ | $136.76M |
| Operating Income | $39.84M↑ | $38.71M↑ | $29.13M↑ | $22.83M↑ | $15.17M |
| Net Income | $24.71M↓ | $29.49M↑ | $27.49M↑ | $26.62M↑ | $8.55M |
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, ...